PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Carl Zeiss Meditec AG ADR (CZMWY)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US14218T1051

CUSIP

14218T105

Sector

Healthcare

Highlights

Market Cap

$5.58B

EPS (TTM)

$2.43

PE Ratio

25.15

PEG Ratio

2.56

Total Revenue (TTM)

$1.96B

Gross Profit (TTM)

$1.27B

EBITDA (TTM)

$191.38M

Year Range

$60.72 - $131.75

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
CZMWY vs. XDWT.L CZMWY vs. SCHD
Popular comparisons:
CZMWY vs. XDWT.L CZMWY vs. SCHD

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Carl Zeiss Meditec AG ADR, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


200.00%250.00%300.00%350.00%JuneJulyAugustSeptemberOctoberNovember
163.20%
208.33%
CZMWY (Carl Zeiss Meditec AG ADR)
Benchmark (^GSPC)

Returns By Period

Carl Zeiss Meditec AG ADR had a return of -43.12% year-to-date (YTD) and -34.15% in the last 12 months. Over the past 10 years, Carl Zeiss Meditec AG ADR had an annualized return of 11.40%, while the S&P 500 benchmark had an annualized return of 11.11%, indicating that Carl Zeiss Meditec AG ADR performed slightly bigger than the benchmark.


CZMWY

YTD

-43.12%

1M

-12.80%

6M

-40.72%

1Y

-34.15%

5Y (annualized)

-11.19%

10Y (annualized)

11.40%

^GSPC (Benchmark)

YTD

23.08%

1M

0.10%

6M

10.70%

1Y

30.05%

5Y (annualized)

13.52%

10Y (annualized)

11.11%

Monthly Returns

The table below presents the monthly returns of CZMWY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-1.94%14.98%2.59%-15.86%-12.52%-23.58%-2.19%6.87%7.97%-21.09%-43.12%
202313.89%-6.53%4.70%-3.31%-16.87%-3.33%7.50%-14.29%-11.92%-1.47%3.96%21.56%-12.50%
2022-24.52%-0.30%3.96%-22.32%4.79%-10.54%21.68%-13.81%-15.71%15.06%9.79%-5.38%-39.79%
202117.62%-3.73%0.10%16.81%5.20%4.47%15.24%-0.82%-12.87%4.60%-1.06%5.54%58.29%
2020-4.05%-15.01%-6.08%1.63%3.98%-4.84%7.53%8.46%12.18%2.00%3.52%-0.37%6.02%
201916.32%-5.96%-1.43%17.37%-4.31%2.21%15.39%4.33%-1.29%-4.37%9.54%6.84%64.60%
20185.73%-5.71%2.92%7.80%1.51%-1.16%13.93%14.18%-5.14%-2.52%-15.86%13.05%26.95%
20171.89%16.21%-1.47%6.24%15.03%0.09%3.05%-6.73%4.81%2.10%11.17%4.88%71.16%
2016-4.90%6.78%-1.68%7.00%18.58%4.63%-7.73%-2.74%5.28%-6.11%-4.57%6.97%20.01%
20151.66%0.86%3.86%-5.52%9.23%1.77%-2.01%9.37%19.88%
20142.36%-0.65%1.70%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of CZMWY is 14, indicating that it is in the bottom 14% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of CZMWY is 1414
Combined Rank
The Sharpe Ratio Rank of CZMWY is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of CZMWY is 1010
Sortino Ratio Rank
The Omega Ratio Rank of CZMWY is 1111
Omega Ratio Rank
The Calmar Ratio Rank of CZMWY is 1818
Calmar Ratio Rank
The Martin Ratio Rank of CZMWY is 2121
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Carl Zeiss Meditec AG ADR (CZMWY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for CZMWY, currently valued at -0.79, compared to the broader market-4.00-2.000.002.00-0.792.48
The chart of Sortino ratio for CZMWY, currently valued at -0.97, compared to the broader market-4.00-2.000.002.004.00-0.973.33
The chart of Omega ratio for CZMWY, currently valued at 0.87, compared to the broader market0.501.001.502.000.871.46
The chart of Calmar ratio for CZMWY, currently valued at -0.46, compared to the broader market0.002.004.006.00-0.463.58
The chart of Martin ratio for CZMWY, currently valued at -1.01, compared to the broader market0.0010.0020.0030.00-1.0115.96
CZMWY
^GSPC

The current Carl Zeiss Meditec AG ADR Sharpe ratio is -0.79. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Carl Zeiss Meditec AG ADR with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.

Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
-0.79
2.48
CZMWY (Carl Zeiss Meditec AG ADR)
Benchmark (^GSPC)

Dividends

Dividend History

Carl Zeiss Meditec AG ADR provided a 1.94% dividend yield over the last twelve months, with an annual payout of $1.19 per share. The company has been increasing its dividends for 2 consecutive years.


0.00%0.50%1.00%1.50%2.00%$0.00$0.50$1.00$1.5020132014201520162017201820192020202120222023
Dividends
Dividend Yield
PeriodTTM20232022202120202019201820172016201520142013
Dividend$1.19$1.17$0.99$0.60$1.45$0.62$0.66$0.46$0.43$0.47$0.62$0.53

Dividend yield

1.94%1.08%0.79%0.29%1.09%0.49%0.84%0.74%1.18%1.52%2.35%0.00%

Monthly Dividends

The table displays the monthly dividend distributions for Carl Zeiss Meditec AG ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$1.19$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.19
2023$0.00$0.00$1.17$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.17
2022$0.00$0.00$0.99$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.99
2021$0.00$0.00$0.00$0.00$0.60$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.60
2020$0.00$0.00$0.71$0.00$0.00$0.00$0.00$0.74$0.00$0.00$0.00$0.00$1.45
2019$0.00$0.00$0.62$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.62
2018$0.00$0.00$0.00$0.66$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.66
2017$0.00$0.00$0.00$0.00$0.46$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.46
2016$0.00$0.00$0.00$0.43$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.43
2015$0.47$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.47
2014$0.62$0.00$0.00$0.62
2013$0.53$0.53

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%1.9%
Carl Zeiss Meditec AG ADR has a dividend yield of 1.94%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%2.6%
Carl Zeiss Meditec AG ADR has a payout ratio of 2.63%, which is below the market average. This means Carl Zeiss Meditec AG ADR returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-73.07%
-2.18%
CZMWY (Carl Zeiss Meditec AG ADR)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Carl Zeiss Meditec AG ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Carl Zeiss Meditec AG ADR was 73.35%, occurring on Nov 13, 2024. The portfolio has not yet recovered.

The current Carl Zeiss Meditec AG ADR drawdown is 73.07%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-73.35%Sep 17, 2021795Nov 13, 2024
-43.66%Jan 21, 202041Mar 18, 2020140Oct 7, 2020181
-22.89%Aug 30, 201863Nov 30, 201834Jan 23, 201997
-21.25%Jul 14, 201688Nov 23, 201656Feb 17, 2017144
-14.33%Sep 9, 201933Oct 23, 201925Dec 3, 201958

Volatility

Volatility Chart

The current Carl Zeiss Meditec AG ADR volatility is 11.59%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
11.59%
4.06%
CZMWY (Carl Zeiss Meditec AG ADR)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Carl Zeiss Meditec AG ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Carl Zeiss Meditec AG ADR compared to its peers in the Medical Instruments & Supplies industry.


PE Ratio
50.0100.0150.0200.025.2
The chart displays the price to earnings (P/E) ratio for CZMWY in comparison to other companies of the Medical Instruments & Supplies industry. Currently, CZMWY has a PE value of 25.2. This PE value is considered to be low compared to the rest of the industry.
PEG Ratio
0.05.010.015.020.02.6
The chart displays the price to earnings to growth (PEG) ratio for CZMWY in comparison to other companies of the Medical Instruments & Supplies industry. Currently, CZMWY has a PEG value of 2.6. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Carl Zeiss Meditec AG ADR.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items